Complexin-3 Antibodies

Santa Cruz Biotechnology features a diverse variety of Complexin-3 monoclonal antibodies for research focused on understanding Complexin-3's role in synaptic transmission and neuronal communication. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Complexin-3 regulates neurotransmitter release by controlling synaptic vesicle fusion and modulating synaptic activity. Research on Complexin-3 advances understanding of neurobiology and synaptic disorders, contributing to knowledge about neurological conditions and potential treatments. Studying Complexin-3 expression patterns helps reveal its distribution across different neural tissues and cell types. Advanced research techniques enable detailed examination of Complexin-3's molecular interactions and regulatory mechanisms. Investigating Complexin-3's functional domains provides insights into how it coordinates with other synaptic proteins. Understanding Complexin-3's role in calcium-dependent neurotransmitter release mechanisms helps explain synaptic plasticity and neural circuit function. Santa Cruz Biotechnology monoclonal antibodies for Complexin-3 research support scientists worldwide in advancing neuroscience knowledge and developing potential therapeutic strategies for neurological disorders.